Self‐Delivered Transformable Nanosystem Capable of Enhancing Photodynamic Effectiveness and Multi‐Target Ameliorating Immunosuppression for Treatment of Breast Cancer and Lung Metastasis
Source abstract
Abstract
Abstract Homogeneous distribution and adequate accumulation of photosensitizer in tumor are essential for effective photodynamic therapy (PDT). However, the intricate tumor microenvironment (TME) often poses great challenges to the deep penetration and retention of therapeutic agents in tumor. Moreover, the important effect of PDT to induce specific antitumor immune response is impeded by multiple immunosuppressive mechanisms within TME. Confronting these issues, here a rationally designed nanosystem (SUN‐NPA) with acid‐responsive sphere‐to‐fiber transformation ability by leveraging the characters of drug molecules is proposed to achieve self‐delivery of photosensitizer Chlorin e6 (Ce6) and two small‐molecule immunomodulators, metformin (MET) and sunitinib (SUN). The spatiotemporal controlled transformation enables homogeneous distribution and high accumulation of drugs to achieve enduring PDT and complete tumor elimination. Meanwhile, the co‐delivered MET and SUN alleviate tumor immunosuppression from multiple aspects, effectively synergizing with PDT to ignite potent host immune response and long‐lasting immunological memory against tumor cells. The artful integration of enhanced PDT and activated antitumor immunity realized by SUN‐NPA leads to the significant inhibition of tumor growth and metastasis, exhibiting great potential for oncotherapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry Sichuan Engineering Laboratory for Plant‐Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology West China School of Pharmacy Sichuan University Chengdu 610064 P. R. China
Institute of Cytology of the Russian Academy of Sciences (RAS) St. Petersburg 194064 Russia
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (37)
Show source-provided references
1. 10.1016/j.biopha.2018.07.04910.1016/j.biopha.2018.07.049 ↗
2. 10.1021/acsnano.7b0821910.1021/acsnano.7b08219 ↗
3. 10.1002/smll.20230059410.1002/smll.202300594 ↗
4. 10.1002/anie.20201559010.1002/anie.202015590 ↗
5. 10.1021/acsnano.0c0676510.1021/acsnano.0c06765 ↗
6. 10.1016/j.biomaterials.2020.11982710.1016/j.biomaterials.2020.119827 ↗
7. 10.1016/j.bioactmat.2021.06.01910.1016/j.bioactmat.2021.06.019 ↗
8. 10.1016/j.bioactmat.2023.02.01510.1016/j.bioactmat.2023.02.015 ↗
9. 10.1016/j.cell.2015.08.01610.1016/j.cell.2015.08.016 ↗
10. 10.4161/onci.2596110.4161/onci.25961 ↗
11. 10.1016/j.apsb.2022.11.00110.1016/j.apsb.2022.11.001 ↗
12. 10.1021/acsnano.5b0201710.1021/acsnano.5b02017 ↗
13. 10.1002/adfm.20200976510.1002/adfm.202009765 ↗
14. 10.1021/acscentsci.9b0113910.1021/acscentsci.9b01139 ↗
15. 10.1016/j.cclet.2022.10789110.1016/j.cclet.2022.107891 ↗
16. 10.1016/j.cclet.2022.05.03210.1016/j.cclet.2022.05.032 ↗
17. 10.1021/acsnano.7b0078110.1021/acsnano.7b00781 ↗
18. 10.1016/j.apsb.2022.03.01010.1016/j.apsb.2022.03.010 ↗
19. 10.1021/acs.molpharmaceut.5b0099210.1021/acs.molpharmaceut.5b00992 ↗
20. 10.1016/j.colsurfa.2023.13222110.1016/j.colsurfa.2023.132221 ↗
21. 10.1016/j.jconrel.2021.12.03210.1016/j.jconrel.2021.12.032 ↗
22. 10.1002/anie.20130265810.1002/anie.201302658 ↗
23. 10.1021/acsnano.2c0789510.1021/acsnano.2c07895 ↗
24. 10.1038/s41573-018-0007-y10.1038/s41573-018-0007-y ↗
25. 10.1186/s13045-022-01282-810.1186/s13045-022-01282-8 ↗
26. 10.1186/s13045-021-01193-010.1186/s13045-021-01193-0 ↗
27. 10.1158/2326-6066.CIR-16-010310.1158/2326-6066.CIR-16-0103 ↗
28. 10.1039/D1BM01303C10.1039/D1BM01303C ↗
29. 10.1016/j.molcel.2018.07.03010.1016/j.molcel.2018.07.030 ↗
30. 10.1002/adfm.20200714910.1002/adfm.202007149 ↗
31. 10.2217/imt.10.7910.2217/imt.10.79 ↗
32. 10.1158/0008-5472.CAN-08-470910.1158/0008-5472.CAN-08-4709 ↗
33. 10.1002/ijc.2621910.1002/ijc.26219 ↗
34. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
35. 10.1002/adfm.20180846210.1002/adfm.201808462 ↗
36. 10.3390/ijms16051105510.3390/ijms160511055 ↗
37. 10.1038/bjc.2015.10110.1038/bjc.2015.101 ↗